scispace - formally typeset
J

Justin Liu

Researcher at University of California, San Diego

Publications -  25
Citations -  2249

Justin Liu is an academic researcher from University of California, San Diego. The author has contributed to research in topics: 3D bioprinting & Chemistry. The author has an hindex of 14, co-authored 21 publications receiving 1564 citations. Previous affiliations of Justin Liu include University Health Network.

Papers
More filters
Journal ArticleDOI

Deterministically patterned biomimetic human iPSC-derived hepatic model via rapid 3D bioprinting

TL;DR: 3D hydrogel-based triculture model that embeds hiPSC-HPCs with human umbilical vein endothelial cells and adipose-derived stem cells in a microscale hexagonal architecture is presented and finds improved morphological organization, higher liver-specific gene expression levels, increased metabolic product secretion, and enhanced cytochrome P450 induction.
Journal ArticleDOI

Direct 3D bioprinting of prevascularized tissue constructs with complex microarchitecture.

TL;DR: This work created prevascularized tissues with complex three-dimensional (3D) microarchitectures using a rapid biop printing method - microscale continuous optical bioprinting (μCOB) that can be broadly applicable to the engineering and translation of various functional tissues.
Journal ArticleDOI

3D bioprinting of functional tissue models for personalized drug screening and in vitro disease modeling

TL;DR: This review presents state-of-the-art 3D bioprinting techniques and discusses the choice of cell source and biomaterials for building functional tissue models that can be used for personalized drug screening and disease modeling.
Journal ArticleDOI

3D printing of biomimetic microstructures for cancer cell migration.

TL;DR: 3D cancer tissue model created using 3D projection printing has the potential to be a powerful tool for future drug discoveries and cancer migration studies.
Journal ArticleDOI

Rapid 3D bioprinting of decellularized extracellular matrix with regionally varied mechanical properties and biomimetic microarchitecture.

TL;DR: A rapid light-based 3D bioprinting process and an engineered cancer tissue platform possessing tissue-scale organization and distinct regional stiffness enabled the visualization of HepG2 stromal invasion from the nodule with cirrhotic stiffness.